Earnings call transcripts

Management framed 2026 as a transition year, with short-cycle weakness offsetting strong commercial HVAC, aftermarket and data-center growth.

Management framed the quarter as operationally strong but warned memory availability, not demand, will determine handset growth through fiscal 2026.

Management framed growth as broad brand momentum, while acknowledging softer organic trends and emphasizing disciplined expansion, investment, and share gains.

Management framed the quarter as broad-based execution, raising FY26 EPS while stressing specialty growth, automation, and resilient manufacturer economics.

Management framed 2026 as a solutions-led, AI-driven growth year, with public-sector timing and memory constraints limiting near-term visibility.

Management framed 2025 as unusually favorable but fundamentally strong, with 2026 growth relying on distribution momentum and normalized catastrophe assumptions.

Management framed 2025 as a positive inflection point, with reliability, refining costs and Midstream growth supporting stronger future returns.

Management presented strong 2025 execution as durable growth, while repeatedly qualifying stop-loss recovery because healthcare claims uncertainty remains unusually high.

Management framed the quarter as an improving underlying business obscured by temporary cell-therapy order timing and uneven end-market recovery.

Management framed Q4 as evidence of broad diversification, disciplined underwriting and long-term transformation despite increasingly competitive markets.

Management framed 2026 growth as broad-based despite a slower EP market and temporary product disruptions, with confidence in its long-range goals unchanged.

Management framed 2026 as a transition year, with tariff and volume-deleverage pressure front-loaded while supply-chain actions and brand investments support recovery.